MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Enterprise Value (2015 - 2026)

MetaVia's (MTVA) quarterly Enterprise Value came in at -$10.3 million in Q4 2025, up 35.56% YoY from -$7.6 million in Q4 2024, and up 27.78% on a QoQ basis from -$14.3 million in Q3 2025.

MetaVia (MTVA) Enterprise Value (2015 - 2026) Analysis & Trends

MetaVia (MTVA) has 11 years of Enterprise Value data on file, last reported at -$10.3 million in Q4 2025.

  • Quarterly Enterprise Value rose 35.56% year-over-year to -$10.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$10.3 million (up 35.56% YoY) and the FY2025 annual result came in at -$10.3 million, up 35.56% from the prior year.
  • Enterprise Value improved to -$10.3 million in Q4 2025, from -$14.3 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$6.4 million in Q3 2022 to a low of -$33.4 million in Q4 2022.
  • A 5-year average of -$17.5 million and a median of -$16.0 million in 2024 frame the typical range for Enterprise Value.
  • Annual changes were most pronounced in 2021 — Enterprise Value tumbled 86800.0% — and 2024, when it surged 48.11%.
  • Tracing MTVA's Enterprise Value over 5 years: stood at -$16.4 million in 2021, then plunged by 103.6% to -$33.4 million in 2022, then surged by 32.64% to -$22.5 million in 2023, then advanced by 28.66% to -$16.0 million in 2024, then soared by 35.56% to -$10.3 million in 2025.
  • The last three Enterprise Value figures came in at -$10.3 million (Q4 2025), -$14.3 million (Q3 2025), and -$17.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 2.12 Bn
10 MetaVia 8.72 Mn -3.92 Mn - -12.64 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.64 Mn
Dec 31, 2025 -10.33 Mn
Sep 30, 2025 -14.31 Mn
Jun 30, 2025 -17.60 Mn
Mar 31, 2025 -11.19 Mn
Dec 31, 2024 -16.03 Mn
Sep 30, 2024 -21.71 Mn
Jun 30, 2024 -28.05 Mn
Mar 31, 2024 -15.99 Mn
Dec 31, 2023 -22.47 Mn
Sep 30, 2023 -25.84 Mn
Jun 30, 2023 -28.69 Mn
Mar 31, 2023 -30.81 Mn
Dec 31, 2022 -33.36 Mn
Sep 30, 2022 -6.40 Mn
Jun 30, 2022 -8.85 Mn
Mar 31, 2022 -11.60 Mn
Dec 31, 2021 -16.39 Mn
Sep 30, 2021 -7.00 Mn
Jun 30, 2021 -9.50 Mn